INTRODUCTION
Recent data suggest a favorable prognosis for rectal cancer patients with a pathologic complete response to preoperative combined modality therapy. Prolongation of the interval between preoperative combined modality therapy and surgery (RT-surgery interval) as a means of increasing pathologic complete response rate has not been fully examined.
METHODS
One hundred and fifty-five rectal cancer patients undergoing preoperative pelvic external beam radiation therapy and 5-fluorouracil-based chemotherapy followed by rectal resection were identified. All patients had endorectal ultrasound prior to combined modality therapy. Final pathology reports were reviewed for ypT and ypN stage and margin status. Medical records were reviewed for sphincter preservation, operative time, estimated blood loss, hospital stay, and morbidity (overall, anastomotic, and perineal).
RESULTS
A pathologic complete response (ypT0N0) occurred in 24 patients (15 percent). Median RT-surgery interval was 44 (range, 15-206) days. A pathologic complete response occurred in 19 percent of patients with an interval >44 days, vs. 12 percent in those with an interval ≤44 days (P = 0.27). Downstaging by three stages occurred more frequently in the long-interval group (15 percent vs. 6 percent, P = 0.11). The rates of sphincter preservation, positive margins, estimated blood loss, and operative time were not significantly different. Overall morbidity was similar between groups.
CONCLUSIONS
Our results demonstrate a trend toward increased pathologic complete response rate and downstaging with increased RT-surgery interval. However, sphincter preservation is not increased. Until prospective analyses are conducted assessing the impact of prolonged RT-surgery interval on long-term outcome, the benefit of a prolonged interval between the completion of preoperative combined modality therapy and surgery remains unclear.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
E Kapiteijn CA Marijnen ID Nagtegaal et al. (2001) ArticleTitlePreoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 638–46
InstitutionalAuthorNameColorectal Cancer Collaborative Group (2001) ArticleTitleAdjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials Lancet 358 1291–304
L Ruo JG Guillem S Tickoo et al. (2002) ArticleTitleLong-term prognostic significance of extent of rectal cancer response to preoperative radiation +/− chemotherapy Ann Surg 236 75–81
J Garcia-Aguilar E Hernandez de Anda P Sirivongs SH Lee RD Madoff DA Rothenberger (2003) ArticleTitleA pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum 46 298–304
M Mohiuddin WF Regine WJ John et al. (2000) ArticleTitlePreoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response Int J Radiat Oncol Biol Phys 46 883–8
AK Chan AO Wong J Langevin et al. (2000) ArticleTitlePreoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study Int J Radiat Oncol Biol Phys 48 843–56
RJ Myerson V Valentini EH Birnbaum et al. (2001) ArticleTitleA phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma Int J Radiat Oncol Biol Phys 50 1299–308
MS Anscher C Lee H Hurwitz et al. (2000) ArticleTitleA pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer Int J Radiat Oncol Biol Phys 47 719–24
GM Videtic BJ Fisher FE Perera et al. (1998) ArticleTitlePreoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer Int J Radiat Oncol Biol Phys 42 319–24
SY Ngan BH Burmeister R Fisher et al. (2001) ArticleTitleEarly toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group Int J Radiat Oncol Biol Phys 50 883–7
NA Janjan C Crane BW Feig et al. (2001) ArticleTitleImproved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer Am J Clin Oncol 24 107–12
A Grann C Feng D Wong et al. (2001) ArticleTitlePreoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma Int J Radiat Oncol Biol Phys 49 987–95
BD Minsky AM Cohen WE Enker et al. (1997) ArticleTitlePreoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer Int J Radiat Oncol Biol Phys 37 289–95
BD Minsky E Oreilly D Wong et al. (1999) ArticleTitleDaily low-dose irinotecan (CPT-11) plus pelvic irradiation as preoperative treatment of locally advanced rectal cancer Proc ASCO 18 266a
DE Stein NN Mahmoud PR Anne et al. (2003) ArticleTitleLonger time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma Dis Colon Rectum 46 448–53
C Ratto V Valentini AG Morganti et al. (2003) ArticleTitleCombined-modality therapy in locally advanced primary rectal cancer Dis Colon Rectum 46 59–67
V Valentini C Coco N Cellini et al. (2001) ArticleTitleTen years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies Int J Radiat Oncol Biol Phys 51 371–83
JS Kim MJ Cho KS Song WH Yoon (2002) ArticleTitlePreoperative chemoradiation using oral capecitabine in locally advanced rectal cancer Int J Radiat Oncol Biol Phys 54 403–8
CA Marijnen ID Nagtegaal E Klein Kranenbarg et al. (2001) ArticleTitleNo downstaging after short-term preoperative radiotherapy in rectal cancer patients J Clin Oncol 19 1976–84
Y Francois CJ Nemoz J Baulieux et al. (1999) ArticleTitleInfluence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial J Clin Oncol 17 2396–402
A Grann BD Minsky AM Cohen et al. (1997) ArticleTitlePreliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer Dis Colon Rectum 40 515–22
O Glehen O Chapet M Adham JC Nemoz JP Gerard (2003) ArticleTitleLong-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer Br J Surg 90 996–8
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by the National Cancer Institute, RO1 CA 82534-01 (J.G.G.).
Read at the Meeting of the American Society of Colon and Rectal Surgeons, New Orleans, Louisiana, June 21 to 26, 2003.
About this article
Cite this article
Moore, H., Gittleman, A., Minsky, B. et al. Rate of Pathologic Complete Response With Increased Interval Between Preoperative Combined Modality Therapy and Rectal Cancer Resection. Dis Colon Rectum 47, 279–286 (2004). https://doi.org/10.1007/s10350-003-0062-1
Issue Date:
DOI: https://doi.org/10.1007/s10350-003-0062-1